multi-cancer early detection

The company recently published data on its NGS-based pleural effusion liquid biopsy panel and is launching a large multimodal MCED study in Korea. 

Growth was mainly driven by an increase in colorectal cancer screening revenue, while precision oncology testing income was flat year over year.

The firm recently published the results of a large cancer screening study in asymptomatic people and has launched another in symptomatic people.